ALKS

Alkermes plc News Headlines

$44.12
*  
0.91
 negative 
2.02%
Get ALKS Alerts
*Delayed - data as of Apr. 17, 2014 
Exchange: NASDAQ
Industry: Health Care
Community Rating:
 
 
Symbol List Views
FlashQuotes InfoQuotes
Stock Details
Summary Quote Real-Time Quote After Hours Quote Pre-market Quote Historical Quote Option Chain
CHARTS
Basic Chart Interactive Chart
COMPANY NEWS
Company Headlines Press Releases Market Stream
STOCK ANALYSIS
Analyst Research Guru Analysis Stock Report Competitors Stock Consultant Stock Comparison
FUNDAMENTALS
Call Transcripts Annual Report Income Statement Revenue/EPS SEC Filings Short Interest Dividend History
HOLDINGS
Ownership Summary Institutional Holdings Insiders
(SEC Form 4)
 Save stocks for next time
Viewing
Filtered By
Ordered By

Xenoport's Path Is Long, But The Potential Is There
4/17/2014 8:31:00 PM - Seeking Alpha

Biotech Stock Roundup: MannKind PDUFA Date Pushed Out, Alkermes Impresses with Data - Analyst Blog
4/16/2014 10:07:01 AM - Zacks.com

Gilead Sciences (GILD) Falls: Stock Goes Down 7.3% - Tale of the Tape
4/11/2014 9:00:01 AM - Zacks.com

Halozyme Study Under Clinical Hold - Analyst Blog
4/10/2014 5:40:01 PM - Zacks.com

ImmunoGen Up on Positive Pipeline Data - Analyst Blog
4/10/2014 5:00:01 PM - Zacks.com

Gilead Announces Encouraging Sovaldi Data - Analyst Blog
4/10/2014 4:37:01 PM - Zacks.com

3 Top-Ranked Biotech Stocks on the Rebound - Analyst Blog
4/10/2014 9:22:01 AM - Zacks.com

Cramer's Lightning Round - Kimberly-Clark Is Perfect For Me (4/9/14)
4/10/2014 5:42:00 AM - Seeking Alpha

Oncolytics Reports Additional Data on Reolysin - Analyst Blog
4/9/2014 6:30:01 PM - Zacks.com

Ambit's Oncology Drug in Phase III - Analyst Blog
4/9/2014 4:55:01 PM - Zacks.com

Seattle Genetics Earns Milestone Payment - Analyst Blog
4/9/2014 4:20:01 PM - Zacks.com

Biotech Stock Roundup: MannKind Soars on Panel Vote, Halozyme Plunges on Safety Concerns - Analyst Blog
4/9/2014 12:46:01 PM - Zacks.com

Positive Trial Data Lifts Alkermes - Analyst Blog
4/9/2014 11:50:01 AM - Zacks.com

Pharmacyclics Files sNDA - Analyst Blog
4/9/2014 11:30:01 AM - Zacks.com

ALKS, SGEN To Watch Out, Capstone Dons New Hat, PRTA Pockets $15 Mln
4/9/2014 2:12:00 AM - RTT News

Sanofi to File for Lemtrada Approval Again - Analyst Blog
4/8/2014 7:09:01 PM - Zacks.com

EPO Upholds Alnylam's McSwiggen Patent - Analyst Blog
4/8/2014 7:00:01 PM - Zacks.com

Merck KGaA Starts Study on Tecemotide - Analyst Blog
4/8/2014 6:55:01 PM - Zacks.com

Encouraging Pre-Clinical Data from Celldex - Analyst Blog
4/8/2014 5:40:01 PM - Zacks.com

Intercept Pharma Prices 1M Share Offering, Shares Down - Analyst Blog
4/8/2014 5:00:01 PM - Zacks.com

Pipeline Update from Idenix - Analyst Blog
4/8/2014 4:55:01 PM - Zacks.com

Healthcare Stocks Losing Ground Ahead of Closing Bell; Alkermes Up 3% on Positive Results for Schizophrenia Drug
4/8/2014 3:51:40 PM - MT Newswires

Sector Update: Healthcare
4/8/2014 3:47:21 PM - MT Newswires

Mid-Afternoon Market Update: Markets Recover Slightly as Coal Shows Strength
4/8/2014 3:46:15 PM - Benzinga

Mid-Day Market Update: US Stocks Gain; Gigamon Shares Dip On Lower Forecast
4/8/2014 1:22:43 PM - Benzinga